Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Latham Group, Inc.SWIM · Entity 5107 | GENERAL COUNSEL & SECRETARY | March 15, 2026 | March 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Latham Group, Inc.
Report date March 15, 2026 · Filed March 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 434,238 |
Reported balance
After 2026-03-15 transaction · row 1
1 source rowRow 1 · 2026-03-15 · Tax withholding · Disposed 9,943 · Balance 434,238 |
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Mead Johnson Nutrition Co
Report date June 15, 2017 · Filed June 15, 2017
Section 16 reporting ended · disclosed 2017-06-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-06-15 transaction · row 1
1 source rowRow 1 · 2017-06-15 · Disposition to issuer · Disposed 938 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated February 10, 2017, by and among Mead Johnson Nutrition Company ("MJN"), Reckitt Benckiser Group plc ("RB"), and Marigold Merger Sub, Inc. (the "Merger Agreement"), at the effective time of the merger, each share of MJN common stock held by the reporting person was converted into the right to receive a cash payment equal to $90.00 per share. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-06-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-06-15 · Disposition to issuer · Disposed 1,477 · Balance 0 F2: Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock. F3: Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share. F4: One-fourth of this RSU was scheduled to vest on each of the first, second, third and fourth anniversaries of the February 2, 2015 grant date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-06-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-06-15 · Disposition to issuer · Disposed 1,904 · Balance 0 F2: Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock. F3: Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share. F5: This RSU was originally scheduled to vest on February 26, 2019. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-06-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-06-15 · Disposition to issuer · Disposed 2,612 · Balance 0 F2: Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock. F3: Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share. F6: This RSU was originally scheduled to vest on February 29, 2020. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-06-15 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-06-15 · Disposition to issuer · Disposed 5,981 · Balance 0 F2: Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock. F7: One-third of this RSU was scheduled to vest on each of the first, second and third anniversaries of the February 28, 2017 grant date. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person converted into phantom RSUs representing a number of shares of RB common stock ("RB RSUs"). With this conversion, the reporting person received a number of RB RSUs equal to: (a) the original number of RSUs granted to the reporting person multiplied by $90.00 per share; divided by (b) the RB share closing price on the London Stock Exchange on the closing date of the merger. F8: The RB RSUs will continue to be subject to time-based vesting over the applicable vesting period and, upon vesting, will settle in cash based on the RB share closing price on the London Stock Exchange on the applicable vesting date. In the event that the reporting person's employment is terminated without "Cause" or for "Good Reason" during the vesting period, the RB RSUs will vest in full as of the date of such termination. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-06-15 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2017-06-15 · Disposition to issuer · Disposed 8,971 · Balance 0 F2: Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock. F9: This RSU was originally scheduled to vest on February 28, 2020. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person converted into phantom RSUs representing a number of shares of RB common stock ("RB RSUs"). With this conversion, the reporting person received a number of RB RSUs equal to: (a) the original number of RSUs granted to the reporting person multiplied by $90.00 per share; divided by (b) the RB share closing price on the London Stock Exchange on the closing date of the merger. The RB RSUs will continue to be subject to time-based vesting over the applicable vesting period and, upon vesting, will settle in cash based on the RB share closing price on the London Stock Exchange on the applicable vesting date. In the event that the reporting person's employment is terminated without "Cause" or for "Good Reason" during the vesting period, the RB RSUs will vest in full as of the date of such termination. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $73.76 · Expires 2026-02-28 | Direct | 0 |
Reported balance
After 2017-06-15 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-06-15 · Disposition to issuer · Disposed 17,666 · Balance 0 F10: Pursuant to the Merger Agreement, at the effective time of the merger, the stock options held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock for which such stock option has not been exercised and (ii) the difference, if any, between the merger consideration ($90.00) and the exercise price of the stock option. F11: One-third of this stock option was scheduled to vest on each of the first, second and third anniversaries of the February 29, 2016 grant date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $73.76 · Expires 2026-02-28 | Direct | 0 |
Reported balance
After 2017-06-15 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2017-06-15 · Disposition to issuer · Disposed 29,500 · Balance 0 F10: Pursuant to the Merger Agreement, at the effective time of the merger, the stock options held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock for which such stock option has not been exercised and (ii) the difference, if any, between the merger consideration ($90.00) and the exercise price of the stock option. F12: One-fourth of this stock option was scheduled to vest on each of the first, second, third and fourth anniversaries of the February 29, 2016 grant date. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 2,214 |
Reported balance
After 2017-06-15 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2017-06-15 · Grant · Acquired 1,269 · Balance 2,214 F13: Each performance share ("PSU") represents the contingent right to receive one share of common stock. F14: Represents the target number of PSUs for any one year performance period not yet completed as of the effective time of the Merger to which the reporting person became entitled on an accelerated basis pursuant to the Merger Agreement at the effective time of the Merger. F15: Pursuant to the Merger Agreement, at the effective time of the merger, the PSUs held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the PSU Amount and (ii) $90.00 per share. The PSU Amount represents the total number of shares of Mead Johnson common stock that would have been delivered to the reporting person based on (1) actual performance goal achievement for any completed one year performance periods and (2) target performance goal achievement for any one year performance period not yet completed. F16: These PSUs were originally scheduled to convert into shares of common stock upon vesting and settlement in the first quarter of 2018. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-06-15 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2017-06-15 · Disposition to issuer · Disposed 2,214 · Balance 0 F13: Each performance share ("PSU") represents the contingent right to receive one share of common stock. F15: Pursuant to the Merger Agreement, at the effective time of the merger, the PSUs held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the PSU Amount and (ii) $90.00 per share. The PSU Amount represents the total number of shares of Mead Johnson common stock that would have been delivered to the reporting person based on (1) actual performance goal achievement for any completed one year performance periods and (2) target performance goal achievement for any one year performance period not yet completed. F16: These PSUs were originally scheduled to convert into shares of common stock upon vesting and settlement in the first quarter of 2018. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 4,879 |
Reported balance
After 2017-06-15 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2017-06-15 · Grant · Acquired 3,556 · Balance 4,879 F13: Each performance share ("PSU") represents the contingent right to receive one share of common stock. F14: Represents the target number of PSUs for any one year performance period not yet completed as of the effective time of the Merger to which the reporting person became entitled on an accelerated basis pursuant to the Merger Agreement at the effective time of the Merger. F15: Pursuant to the Merger Agreement, at the effective time of the merger, the PSUs held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the PSU Amount and (ii) $90.00 per share. The PSU Amount represents the total number of shares of Mead Johnson common stock that would have been delivered to the reporting person based on (1) actual performance goal achievement for any completed one year performance periods and (2) target performance goal achievement for any one year performance period not yet completed. F17: These PSUs were originally scheduled to convert into shares of common stock upon vesting and settlement in the first quarter of 2019. |
| Performance SharesSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-06-15 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2017-06-15 · Disposition to issuer · Disposed 4,879 · Balance 0 F13: Each performance share ("PSU") represents the contingent right to receive one share of common stock. F15: Pursuant to the Merger Agreement, at the effective time of the merger, the PSUs held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the PSU Amount and (ii) $90.00 per share. The PSU Amount represents the total number of shares of Mead Johnson common stock that would have been delivered to the reporting person based on (1) actual performance goal achievement for any completed one year performance periods and (2) target performance goal achievement for any one year performance period not yet completed. F17: These PSUs were originally scheduled to convert into shares of common stock upon vesting and settlement in the first quarter of 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated February 10, 2017, by and among Mead Johnson Nutrition Company ("MJN"), Reckitt Benckiser Group plc ("RB"), and Marigold Merger Sub, Inc. (the "Merger Agreement"), at the effective time of the merger, each share of MJN common stock held by the reporting person was converted into the right to receive a cash payment equal to $90.00 per share.
F2: Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock.
F3: Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share.
F4: One-fourth of this RSU was scheduled to vest on each of the first, second, third and fourth anniversaries of the February 2, 2015 grant date.
F5: This RSU was originally scheduled to vest on February 26, 2019.
F6: This RSU was originally scheduled to vest on February 29, 2020.
F7: One-third of this RSU was scheduled to vest on each of the first, second and third anniversaries of the February 28, 2017 grant date. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person converted into phantom RSUs representing a number of shares of RB common stock ("RB RSUs"). With this conversion, the reporting person received a number of RB RSUs equal to: (a) the original number of RSUs granted to the reporting person multiplied by $90.00 per share; divided by (b) the RB share closing price on the London Stock Exchange on the closing date of the merger.
F8: The RB RSUs will continue to be subject to time-based vesting over the applicable vesting period and, upon vesting, will settle in cash based on the RB share closing price on the London Stock Exchange on the applicable vesting date. In the event that the reporting person's employment is terminated without "Cause" or for "Good Reason" during the vesting period, the RB RSUs will vest in full as of the date of such termination.
F9: This RSU was originally scheduled to vest on February 28, 2020. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person converted into phantom RSUs representing a number of shares of RB common stock ("RB RSUs"). With this conversion, the reporting person received a number of RB RSUs equal to: (a) the original number of RSUs granted to the reporting person multiplied by $90.00 per share; divided by (b) the RB share closing price on the London Stock Exchange on the closing date of the merger. The RB RSUs will continue to be subject to time-based vesting over the applicable vesting period and, upon vesting, will settle in cash based on the RB share closing price on the London Stock Exchange on the applicable vesting date. In the event that the reporting person's employment is terminated without "Cause" or for "Good Reason" during the vesting period, the RB RSUs will vest in full as of the date of such termination.
F10: Pursuant to the Merger Agreement, at the effective time of the merger, the stock options held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock for which such stock option has not been exercised and (ii) the difference, if any, between the merger consideration ($90.00) and the exercise price of the stock option.
F11: One-third of this stock option was scheduled to vest on each of the first, second and third anniversaries of the February 29, 2016 grant date.
F12: One-fourth of this stock option was scheduled to vest on each of the first, second, third and fourth anniversaries of the February 29, 2016 grant date.
F13: Each performance share ("PSU") represents the contingent right to receive one share of common stock.
F14: Represents the target number of PSUs for any one year performance period not yet completed as of the effective time of the Merger to which the reporting person became entitled on an accelerated basis pursuant to the Merger Agreement at the effective time of the Merger.
F15: Pursuant to the Merger Agreement, at the effective time of the merger, the PSUs held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the PSU Amount and (ii) $90.00 per share. The PSU Amount represents the total number of shares of Mead Johnson common stock that would have been delivered to the reporting person based on (1) actual performance goal achievement for any completed one year performance periods and (2) target performance goal achievement for any one year performance period not yet completed.
F16: These PSUs were originally scheduled to convert into shares of common stock upon vesting and settlement in the first quarter of 2018.
F17: These PSUs were originally scheduled to convert into shares of common stock upon vesting and settlement in the first quarter of 2019.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2026 Filed Mar 16, 2026 14:23 UTC | Latham Group, Inc. SWIM · Entity 5107 | Tax withholdingCommon stock, par value $0.0001 per share | 9,943 | $6.02 | $59,856.86 |
DisclosureSEC source: 0001539134-26-000007 · wk-form4_1773685428.xml · nonDerivative · entry 1 Sheller Patrick M · CIK 0001539134 · GENERAL COUNSEL & SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 434,238 Read SEC document |
| March 07, 2026 Filed Mar 9, 2026 15:27 UTC | Latham Group, Inc. SWIM · Entity 5107 | Tax withholdingCommon stock, par value $0.0001 per share | 3,436 | $6.30 | $21,646.80 |
DisclosureSEC source: 0001539134-26-000005 · wk-form4_1773084447.xml · nonDerivative · entry 3 Sheller Patrick M · CIK 0001539134 · GENERAL COUNSEL & SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 444,181 Read SEC document |
| March 06, 2026 Filed Mar 9, 2026 15:27 UTC | Latham Group, Inc. SWIM · Entity 5107 | GrantCommon stock, par value $0.0001 per share | 47,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001539134-26-000005 · wk-form4_1773084447.xml · nonDerivative · entry 2 Sheller Patrick M · CIK 0001539134 · GENERAL COUNSEL & SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 447,617 F2 · shares: Represents restricted stock units granted on March 6, 2026. 15,674 shares will vest on each of March 6, 2027 and 2028. 15,676 shares will vest on March 6, 2029. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 15:27 UTC | Latham Group, Inc. SWIM · Entity 5107 | GrantCommon stock, par value $0.0001 per share | 9,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001539134-26-000005 · wk-form4_1773084447.xml · nonDerivative · entry 1 Sheller Patrick M · CIK 0001539134 · GENERAL COUNSEL & SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,593 F1 · shares: Indicates performance stock units ("PSUs") earned over a one year performance period as granted on March 7, 2025 under the Issuer's 2021 Omnibus Equity Incentive Plan. The PSUs will vest on March 7, 2028. Read SEC document |
| March 01, 2026 Filed Mar 2, 2026 16:58 UTC | Latham Group, Inc. SWIM · Entity 5107 | Tax withholdingCommon stock, par value $0.0001 per share | 9,250 | $6.71 | $62,067.50 |
DisclosureSEC source: 0001539134-26-000003 · wk-form4_1772488705.xml · nonDerivative · entry 1 Sheller Patrick M · CIK 0001539134 · GENERAL COUNSEL & SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 391,431 Read SEC document |
| August 08, 2025 Filed Aug 8, 2025 18:02 UTC | Latham Group, Inc. SWIM · Entity 5107 | Tax withholdingCommon Stock, par value $0.0001 per share | 3,921 | $7.38 | $28,936.98 |
DisclosureSEC source: 0001415889-25-021361 · form4-08082025_100801.xml · nonDerivative · entry 1 Sheller Patrick M · CIK 0001539134 · GENERAL COUNSEL & SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,681 Read SEC document |
| March 15, 2025 Filed Mar 17, 2025 17:14 UTC | Latham Group, Inc. SWIM · Entity 5107 | Tax withholdingCommon Stock, par value $0.0001 per share | 9,943 | $7.29 | $72,484.47 |
DisclosureSEC source: 0001415889-25-008232 · form4-03172025_090335.xml · nonDerivative · entry 1 Sheller Patrick M · CIK 0001539134 · GENERAL COUNSEL & SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 404,602 Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 21:37 UTC | Latham Group, Inc. SWIM · Entity 5107 | GrantCommon Stock, par value $0.0001 per share | 46,904 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-007612 · form4-03112025_010316.xml · nonDerivative · entry 2 Sheller Patrick M · CIK 0001539134 · GENERAL COUNSEL & SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 414,545 F2 · shares: Represents restricted stock units granted on March 7, 2025. 11,726 shares will vest on each of March 7, 2026, 2027, 2028 and 2029. Read SEC document |
| March 05, 2025 Filed Mar 10, 2025 21:37 UTC | Latham Group, Inc. SWIM · Entity 5107 | GrantCommon Stock, par value $0.0001 per share | 106,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-007612 · form4-03112025_010316.xml · nonDerivative · entry 1 Sheller Patrick M · CIK 0001539134 · GENERAL COUNSEL & SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 367,641 F1 · shares: Indicates performance stock units ("PSUs") earned over a one year performance period as granted on March 15, 2024 under the Issuer's 2021 Omnibus Equity Incentive Plan. The PSUs will vest on March 15, 2027. Read SEC document |
| March 01, 2025 Filed Mar 3, 2025 19:21 UTC | Latham Group, Inc. SWIM · Entity 5107 | Tax withholdingCommon Stock, par value $0.0001 per share | 9,359 | $5.91 | $55,311.69 |
DisclosureSEC source: 0001415889-25-006282 · form4-03042025_120342.xml · nonDerivative · entry 1 Sheller Patrick M · CIK 0001539134 · GENERAL COUNSEL & SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,595 Read SEC document |
| August 09, 2024 Filed Aug 9, 2024 20:50 UTC | Latham Group, Inc. SWIM · Entity 5107 | SaleCommon Stock, par value $0.0001 per share | 3,942 | $5.08 | $20,025.36 |
DisclosureSEC source: 0001415889-24-021061 · form4-08102024_120805.xml · nonDerivative · entry 1 Sheller Patrick M · CIK 0001539134 · GENERAL COUNSEL & SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 270,954 F1 · shares: Represents shares of stock sold in an automatic "sell-to-cover" transaction to cover taxes due on RSUs that vested on August 8, 2024. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 18:58 UTC | Latham Group, Inc. SWIM · Entity 5107 | GrantCommon Stock, par value $0.0001 per share | 135,732 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-008345 · form4-03182024_100351.xml · nonDerivative · entry 1 Sheller Patrick M · CIK 0001539134 · GENERAL COUNSEL & SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 274,896 F1 · shares: Represents restricted stock units granted on March 15, 2024. 33,933 shares will vest on each of March 15, 2025, 2026, 2027, and 2028. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 18:40 UTC | Latham Group, Inc. SWIM · Entity 5107 | SaleCommon Stock, par value $0.0001 per share | 10,431 | $3.05 | $31,814.55 |
DisclosureSEC source: 0001415889-24-006861 · form4-03052024_110356.xml · nonDerivative · entry 1 Sheller Patrick M · CIK 0001539134 · GENERAL COUNSEL & SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,164 F1 · shares: Represents shares of stock sold in an automatic "sell-to-cover" transaction to cover taxes due on RSUs that vested on March 1, 2024. Read SEC document |
| August 09, 2023 Filed Aug 10, 2023 09:26 UTC | Latham Group, Inc. SWIM · Entity 5107 | SaleCommon Stock, par value $0.0001 per share | 3,968 | $4.40 | $17,459.20 |
DisclosureSEC source: 0001415889-23-012012 · form4-08102023_010835.xml · nonDerivative · entry 2 Sheller Patrick M · CIK 0001539134 · GENERAL COUNSEL & SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,595 F2 · shares: Represents shares of common stock sold in an automatic "sell-to-cover" transaction to cover taxes due on the RSUs that vested on August 8, 2023. Read SEC document |
| May 02, 2023 Filed May 4, 2023 17:38 UTC | Latham Group, Inc. SWIM · Entity 5107 | GrantStock Appreciation Right · Derivative | 103,618 | $0.00 Strike: $3.24 | $0.00 |
DisclosureSEC source: 0001415889-23-007359 · form4-05042023_090516.xml · derivative · entry 1 Sheller Patrick M · CIK 0001539134 · GENERAL COUNSEL & SECRETARY 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,618 Underlying: Common Stock, par value $0.0001 per share · 103,618 shares Expires 2033-03-01 F1 · derivative.exercise_date: The stock appreciation right ("SAR") was granted and effective on March 1, 2023, subject to stockholder approval of an amendment to the Latham Group, Inc. 2021 Omnibus Equity Incentive Plan, which was received on May 2, 2023. The SAR will vest in four equal installments (rounded down to the nearest whole number) on each anniversary of March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 19:16 UTC | Latham Group, Inc. SWIM · Entity 5107 | GrantCommon Stock, par value $0.0001 per share | 113,426 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-004241 · form4-03042023_120337.xml · nonDerivative · entry 1 Sheller Patrick M · CIK 0001539134 · GENERAL COUNSEL & SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,563 F1 · shares: Represents restricted stock units ("RSUs") granted on 03/01/2023. 28,356 shares will vest on each of March 1, 2024, 2025 and 2026 and 28,358 RSUs will vest on March 1, 2027. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 15:47 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | Disposition to issuerPerformance Shares · Derivative | 4,879 | $90.00 | $439,110.00 |
DisclosureSEC source: 0001104659-17-039522 · a4.xml · derivative · entry 12 Sheller Patrick M · CIK 0001539134 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,879 shares Expires not disclosed F13 · derivative.exercise_price: Each performance share ("PSU") represents the contingent right to receive one share of common stock. F15 · price: Pursuant to the Merger Agreement, at the effective time of the merger, the PSUs held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the PSU Amount and (ii) $90.00 per share. The PSU Amount represents the total number of shares of Mead Johnson common stock that would have been delivered to the reporting person based on (1) actual performance goal achievement for any completed one year performance periods and (2) target performance goal achievement for any one year performance period not yet completed. F15 · derivative.exercise_date: Pursuant to the Merger Agreement, at the effective time of the merger, the PSUs held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the PSU Amount and (ii) $90.00 per share. The PSU Amount represents the total number of shares of Mead Johnson common stock that would have been delivered to the reporting person based on (1) actual performance goal achievement for any completed one year performance periods and (2) target performance goal achievement for any one year performance period not yet completed. F17 · derivative.exercise_date: These PSUs were originally scheduled to convert into shares of common stock upon vesting and settlement in the first quarter of 2019. F15 · derivative.expiration_date: Pursuant to the Merger Agreement, at the effective time of the merger, the PSUs held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the PSU Amount and (ii) $90.00 per share. The PSU Amount represents the total number of shares of Mead Johnson common stock that would have been delivered to the reporting person based on (1) actual performance goal achievement for any completed one year performance periods and (2) target performance goal achievement for any one year performance period not yet completed. F17 · derivative.expiration_date: These PSUs were originally scheduled to convert into shares of common stock upon vesting and settlement in the first quarter of 2019. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 15:47 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | GrantPerformance Shares · Derivative | 3,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-039522 · a4.xml · derivative · entry 11 Sheller Patrick M · CIK 0001539134 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,879 Underlying: Common Stock · 3,556 shares Expires not disclosed F13 · derivative.exercise_price: Each performance share ("PSU") represents the contingent right to receive one share of common stock. F14 · shares: Represents the target number of PSUs for any one year performance period not yet completed as of the effective time of the Merger to which the reporting person became entitled on an accelerated basis pursuant to the Merger Agreement at the effective time of the Merger. F15 · derivative.exercise_date: Pursuant to the Merger Agreement, at the effective time of the merger, the PSUs held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the PSU Amount and (ii) $90.00 per share. The PSU Amount represents the total number of shares of Mead Johnson common stock that would have been delivered to the reporting person based on (1) actual performance goal achievement for any completed one year performance periods and (2) target performance goal achievement for any one year performance period not yet completed. F17 · derivative.exercise_date: These PSUs were originally scheduled to convert into shares of common stock upon vesting and settlement in the first quarter of 2019. F15 · derivative.expiration_date: Pursuant to the Merger Agreement, at the effective time of the merger, the PSUs held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the PSU Amount and (ii) $90.00 per share. The PSU Amount represents the total number of shares of Mead Johnson common stock that would have been delivered to the reporting person based on (1) actual performance goal achievement for any completed one year performance periods and (2) target performance goal achievement for any one year performance period not yet completed. F17 · derivative.expiration_date: These PSUs were originally scheduled to convert into shares of common stock upon vesting and settlement in the first quarter of 2019. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 15:47 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | Disposition to issuerPerformance Shares · Derivative | 2,214 | $90.00 | $199,260.00 |
DisclosureSEC source: 0001104659-17-039522 · a4.xml · derivative · entry 10 Sheller Patrick M · CIK 0001539134 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,214 shares Expires not disclosed F13 · derivative.exercise_price: Each performance share ("PSU") represents the contingent right to receive one share of common stock. F15 · price: Pursuant to the Merger Agreement, at the effective time of the merger, the PSUs held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the PSU Amount and (ii) $90.00 per share. The PSU Amount represents the total number of shares of Mead Johnson common stock that would have been delivered to the reporting person based on (1) actual performance goal achievement for any completed one year performance periods and (2) target performance goal achievement for any one year performance period not yet completed. F15 · derivative.exercise_date: Pursuant to the Merger Agreement, at the effective time of the merger, the PSUs held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the PSU Amount and (ii) $90.00 per share. The PSU Amount represents the total number of shares of Mead Johnson common stock that would have been delivered to the reporting person based on (1) actual performance goal achievement for any completed one year performance periods and (2) target performance goal achievement for any one year performance period not yet completed. F16 · derivative.exercise_date: These PSUs were originally scheduled to convert into shares of common stock upon vesting and settlement in the first quarter of 2018. F15 · derivative.expiration_date: Pursuant to the Merger Agreement, at the effective time of the merger, the PSUs held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the PSU Amount and (ii) $90.00 per share. The PSU Amount represents the total number of shares of Mead Johnson common stock that would have been delivered to the reporting person based on (1) actual performance goal achievement for any completed one year performance periods and (2) target performance goal achievement for any one year performance period not yet completed. F16 · derivative.expiration_date: These PSUs were originally scheduled to convert into shares of common stock upon vesting and settlement in the first quarter of 2018. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 15:47 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | GrantPerformance Shares · Derivative | 1,269 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-039522 · a4.xml · derivative · entry 9 Sheller Patrick M · CIK 0001539134 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,214 Underlying: Common Stock · 1,269 shares Expires not disclosed F13 · derivative.exercise_price: Each performance share ("PSU") represents the contingent right to receive one share of common stock. F14 · shares: Represents the target number of PSUs for any one year performance period not yet completed as of the effective time of the Merger to which the reporting person became entitled on an accelerated basis pursuant to the Merger Agreement at the effective time of the Merger. F15 · derivative.exercise_date: Pursuant to the Merger Agreement, at the effective time of the merger, the PSUs held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the PSU Amount and (ii) $90.00 per share. The PSU Amount represents the total number of shares of Mead Johnson common stock that would have been delivered to the reporting person based on (1) actual performance goal achievement for any completed one year performance periods and (2) target performance goal achievement for any one year performance period not yet completed. F16 · derivative.exercise_date: These PSUs were originally scheduled to convert into shares of common stock upon vesting and settlement in the first quarter of 2018. F15 · derivative.expiration_date: Pursuant to the Merger Agreement, at the effective time of the merger, the PSUs held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the PSU Amount and (ii) $90.00 per share. The PSU Amount represents the total number of shares of Mead Johnson common stock that would have been delivered to the reporting person based on (1) actual performance goal achievement for any completed one year performance periods and (2) target performance goal achievement for any one year performance period not yet completed. F16 · derivative.expiration_date: These PSUs were originally scheduled to convert into shares of common stock upon vesting and settlement in the first quarter of 2018. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 15:47 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | Disposition to issuerStock Option (Right to Buy) · Derivative | 29,500 | $16.24 Strike: $73.76 | $479,080.00 |
DisclosureSEC source: 0001104659-17-039522 · a4.xml · derivative · entry 8 Sheller Patrick M · CIK 0001539134 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,500 shares Expires 2026-02-28 F10 · price: Pursuant to the Merger Agreement, at the effective time of the merger, the stock options held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock for which such stock option has not been exercised and (ii) the difference, if any, between the merger consideration ($90.00) and the exercise price of the stock option. F10 · derivative.exercise_date: Pursuant to the Merger Agreement, at the effective time of the merger, the stock options held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock for which such stock option has not been exercised and (ii) the difference, if any, between the merger consideration ($90.00) and the exercise price of the stock option. F12 · derivative.exercise_date: One-fourth of this stock option was scheduled to vest on each of the first, second, third and fourth anniversaries of the February 29, 2016 grant date. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 15:47 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | Disposition to issuerStock Option (Right to Buy) · Derivative | 17,666 | $16.24 Strike: $73.76 | $286,895.84 |
DisclosureSEC source: 0001104659-17-039522 · a4.xml · derivative · entry 7 Sheller Patrick M · CIK 0001539134 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,666 shares Expires 2026-02-28 F10 · price: Pursuant to the Merger Agreement, at the effective time of the merger, the stock options held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock for which such stock option has not been exercised and (ii) the difference, if any, between the merger consideration ($90.00) and the exercise price of the stock option. F10 · derivative.exercise_date: Pursuant to the Merger Agreement, at the effective time of the merger, the stock options held by the reporting person were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock for which such stock option has not been exercised and (ii) the difference, if any, between the merger consideration ($90.00) and the exercise price of the stock option. F11 · derivative.exercise_date: One-third of this stock option was scheduled to vest on each of the first, second and third anniversaries of the February 29, 2016 grant date. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 15:47 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | Disposition to issuerRestricted Stock Units · Derivative | 8,971 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-17-039522 · a4.xml · derivative · entry 6 Sheller Patrick M · CIK 0001539134 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,971 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock. F9 · price: This RSU was originally scheduled to vest on February 28, 2020. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person converted into phantom RSUs representing a number of shares of RB common stock ("RB RSUs"). With this conversion, the reporting person received a number of RB RSUs equal to: (a) the original number of RSUs granted to the reporting person multiplied by $90.00 per share; divided by (b) the RB share closing price on the London Stock Exchange on the closing date of the merger. The RB RSUs will continue to be subject to time-based vesting over the applicable vesting period and, upon vesting, will settle in cash based on the RB share closing price on the London Stock Exchange on the applicable vesting date. In the event that the reporting person's employment is terminated without "Cause" or for "Good Reason" during the vesting period, the RB RSUs will vest in full as of the date of such termination. F9 · derivative.exercise_date: This RSU was originally scheduled to vest on February 28, 2020. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person converted into phantom RSUs representing a number of shares of RB common stock ("RB RSUs"). With this conversion, the reporting person received a number of RB RSUs equal to: (a) the original number of RSUs granted to the reporting person multiplied by $90.00 per share; divided by (b) the RB share closing price on the London Stock Exchange on the closing date of the merger. The RB RSUs will continue to be subject to time-based vesting over the applicable vesting period and, upon vesting, will settle in cash based on the RB share closing price on the London Stock Exchange on the applicable vesting date. In the event that the reporting person's employment is terminated without "Cause" or for "Good Reason" during the vesting period, the RB RSUs will vest in full as of the date of such termination. F9 · derivative.expiration_date: This RSU was originally scheduled to vest on February 28, 2020. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person converted into phantom RSUs representing a number of shares of RB common stock ("RB RSUs"). With this conversion, the reporting person received a number of RB RSUs equal to: (a) the original number of RSUs granted to the reporting person multiplied by $90.00 per share; divided by (b) the RB share closing price on the London Stock Exchange on the closing date of the merger. The RB RSUs will continue to be subject to time-based vesting over the applicable vesting period and, upon vesting, will settle in cash based on the RB share closing price on the London Stock Exchange on the applicable vesting date. In the event that the reporting person's employment is terminated without "Cause" or for "Good Reason" during the vesting period, the RB RSUs will vest in full as of the date of such termination. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 15:47 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | Disposition to issuerRestricted Stock Units · Derivative | 5,981 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-17-039522 · a4.xml · derivative · entry 5 Sheller Patrick M · CIK 0001539134 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,981 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock. F7 · price: One-third of this RSU was scheduled to vest on each of the first, second and third anniversaries of the February 28, 2017 grant date. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person converted into phantom RSUs representing a number of shares of RB common stock ("RB RSUs"). With this conversion, the reporting person received a number of RB RSUs equal to: (a) the original number of RSUs granted to the reporting person multiplied by $90.00 per share; divided by (b) the RB share closing price on the London Stock Exchange on the closing date of the merger. F8 · price: The RB RSUs will continue to be subject to time-based vesting over the applicable vesting period and, upon vesting, will settle in cash based on the RB share closing price on the London Stock Exchange on the applicable vesting date. In the event that the reporting person's employment is terminated without "Cause" or for "Good Reason" during the vesting period, the RB RSUs will vest in full as of the date of such termination. F7 · derivative.exercise_date: One-third of this RSU was scheduled to vest on each of the first, second and third anniversaries of the February 28, 2017 grant date. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person converted into phantom RSUs representing a number of shares of RB common stock ("RB RSUs"). With this conversion, the reporting person received a number of RB RSUs equal to: (a) the original number of RSUs granted to the reporting person multiplied by $90.00 per share; divided by (b) the RB share closing price on the London Stock Exchange on the closing date of the merger. F8 · derivative.exercise_date: The RB RSUs will continue to be subject to time-based vesting over the applicable vesting period and, upon vesting, will settle in cash based on the RB share closing price on the London Stock Exchange on the applicable vesting date. In the event that the reporting person's employment is terminated without "Cause" or for "Good Reason" during the vesting period, the RB RSUs will vest in full as of the date of such termination. F7 · derivative.expiration_date: One-third of this RSU was scheduled to vest on each of the first, second and third anniversaries of the February 28, 2017 grant date. Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person converted into phantom RSUs representing a number of shares of RB common stock ("RB RSUs"). With this conversion, the reporting person received a number of RB RSUs equal to: (a) the original number of RSUs granted to the reporting person multiplied by $90.00 per share; divided by (b) the RB share closing price on the London Stock Exchange on the closing date of the merger. F8 · derivative.expiration_date: The RB RSUs will continue to be subject to time-based vesting over the applicable vesting period and, upon vesting, will settle in cash based on the RB share closing price on the London Stock Exchange on the applicable vesting date. In the event that the reporting person's employment is terminated without "Cause" or for "Good Reason" during the vesting period, the RB RSUs will vest in full as of the date of such termination. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 15:47 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | Disposition to issuerRestricted Stock Units · Derivative | 2,612 | $90.00 | $235,080.00 |
DisclosureSEC source: 0001104659-17-039522 · a4.xml · derivative · entry 4 Sheller Patrick M · CIK 0001539134 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,612 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock. F3 · price: Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share. F3 · derivative.expiration_date: Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share. F6 · derivative.expiration_date: This RSU was originally scheduled to vest on February 29, 2020. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 15:47 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | Disposition to issuerRestricted Stock Units · Derivative | 1,904 | $90.00 | $171,360.00 |
DisclosureSEC source: 0001104659-17-039522 · a4.xml · derivative · entry 3 Sheller Patrick M · CIK 0001539134 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,904 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock. F3 · price: Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share. F3 · derivative.expiration_date: Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share. F5 · derivative.expiration_date: This RSU was originally scheduled to vest on February 26, 2019. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 15:47 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | Disposition to issuerRestricted Stock Units · Derivative | 1,477 | $90.00 | $132,930.00 |
DisclosureSEC source: 0001104659-17-039522 · a4.xml · derivative · entry 2 Sheller Patrick M · CIK 0001539134 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,477 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive one share of common stock. F3 · price: Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share. F3 · derivative.expiration_date: Pursuant to the Merger Agreement, at the effective time of the merger, the RSUs held by the reporting person vested and were cancelled in exchange for a lump-sum cash payment equal to the product of (i) the number of shares of common stock subject to such RSU immediately prior to the effective time of the merger and (ii) $90.00 per share. F4 · derivative.expiration_date: One-fourth of this RSU was scheduled to vest on each of the first, second, third and fourth anniversaries of the February 2, 2015 grant date. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 15:47 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | Disposition to issuerCommon Stock | 938 | $90.00 | $84,420.00 |
DisclosureSEC source: 0001104659-17-039522 · a4.xml · nonDerivative · entry 1 Sheller Patrick M · CIK 0001539134 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the Agreement and Plan of Merger, dated February 10, 2017, by and among Mead Johnson Nutrition Company ("MJN"), Reckitt Benckiser Group plc ("RB"), and Marigold Merger Sub, Inc. (the "Merger Agreement"), at the effective time of the merger, each share of MJN common stock held by the reporting person was converted into the right to receive a cash payment equal to $90.00 per share. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 11:22 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | GrantPerformance Shares · Derivative | 1,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016300 · doc4.xml · derivative · entry 4 Sheller Patrick M · CIK 0001539134 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,323 Underlying: Common Stock · 1,323 shares Expires not disclosed F6 · derivative.exercise_price: Represents the current tranche of performance shares earned under the 2016 - 2018 performance share award as of February 28, 2017, at which date the Compensation and Management Development Committee certified the extent to which the 2016 performance criteria were met. Each earned performance share represents the contingent right to receive one share of common stock. F3 · price: The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities. F7 · derivative.exercise_date: Each performance share will convert into one share of common stock upon vesting and settlement in the first quarter of 2019. F7 · derivative.expiration_date: Each performance share will convert into one share of common stock upon vesting and settlement in the first quarter of 2019. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 11:22 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | GrantPerformance Shares · Derivative | 945 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016300 · doc4.xml · derivative · entry 3 Sheller Patrick M · CIK 0001539134 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 945 Underlying: Common Stock · 945 shares Expires not disclosed F4 · derivative.exercise_price: Represents the current tranche of performance shares earned under the 2015 - 2017 performance share award as of February 28, 2017, at which date the Compensation and Management Development Committee certified the extent to which the 2016 performance criteria were met. Each earned performance share represents the contingent right to receive one share of common stock. F3 · price: The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities. F5 · derivative.exercise_date: Each performance share will convert into one share of common stock upon vesting and settlement in the first quarter of 2018. F5 · derivative.expiration_date: Each performance share will convert into one share of common stock upon vesting and settlement in the first quarter of 2018. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 11:22 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | GrantRestricted Stock Unit (RSU) · Derivative | 8,971 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016300 · doc4.xml · derivative · entry 2 Sheller Patrick M · CIK 0001539134 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,971 Underlying: Common Stock · 8,971 shares Expires 2020-02-28 F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock. F3 · price: The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 11:22 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | GrantRestricted Stock Unit (RSU) · Derivative | 5,981 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016300 · doc4.xml · derivative · entry 1 Sheller Patrick M · CIK 0001539134 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,981 Underlying: Common Stock · 5,981 shares Expires 2020-02-28 F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock. F3 · price: The derivative securities were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the derivative securities. F2 · derivative.exercise_date: One-third of the restricted stock unit award will vest on each of the first, second and third anniversaries of the grant date. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 11:42 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 738 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-007969 · doc4.xml · derivative · entry 3 Sheller Patrick M · CIK 0001539134 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,477 Underlying: Common Stock · 738 shares Expires 2017-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of common stock. This transaction represents the settlement of vested restricted stock units in shares of common stock. F3 · price: The restricted stock units were granted to the reporting person, and were not sold to the reporting person. As such, the reporting person did not pay any consideration for the restricted stock units. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 11:42 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | Tax withholdingCommon Stock | 269 | $84.38 | $22,698.22 |
DisclosureSEC source: 0001209191-17-007969 · doc4.xml · nonDerivative · entry 2 Sheller Patrick M · CIK 0001539134 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 938 F1 · shares: Represents shares of common stock withheld for payment of taxes upon the vesting of restricted stock units. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 11:42 UTC | Mead Johnson Nutrition Co MJN · Entity 17020 | Exercise / conversionCommon Stock | 738 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007969 · doc4.xml · nonDerivative · entry 1 Sheller Patrick M · CIK 0001539134 · SVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.